North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane (Q36652690)
Jump to navigation
Jump to search
scientific article published on 17 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane |
scientific article published on 17 October 2012 |
Statements
1 reference
North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane (English)
1 reference
Amylou C Dueck
1 reference
Edith A Perez
1 reference
Wilma L Lingle
1 reference
Donald W Northfelt
1 reference
Kostandinos Sideras
1 reference
Timothy J Hobday
1 reference
Kendrith M Rowland
1 reference
Jacob B Allred
1 reference
Robert J Behrens
1 reference
Tom R Fitch
1 reference
Daniel A Nikcevich
1 reference
1 reference
1 reference
Identifiers
1 reference